BofA raised the firm’s price target on Mettler-Toledo (MTD) to $1,260 from $1,200 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Mettler-Toledo initiated with an Overweight at Barclays
- Citi adds ‘upside 90-day short-term view’ on Mettler-Toledo
- MongoDB and Asana downgraded: Wall Street’s top analyst calls
- UBS upgrades Mettler-Toledo to Buy into growth reacceleration
- UBS upgrades Mettler-Toledo to Buy ahead of growth reacceleration